Dear CMPI Friends,
The Center for Medicine inthe Public Interest is pleased to announce the release of two new video interviews this week with Senator Jim Bunning (R-KY) and Dr. Francois Sarkozy.
Senator Jim Bunning was first elected to the U.S. Senate in 1998, winning by a mere 6,766 votes. In 2004 he won by a margin almost 3 ½ times larger than his victory in 1998, and he also won 73 of Kentucky’s 120 counties and secured 873,507 votes - the most votes ever for a U.S. Senate candidate from Kentucky.
As a youngster in Northern Kentucky, Bunning fell in love with baseball and even then he displayed a competitive spirit and a willingness to work hard. That combination carried him on to a highly successful 17-year career as a Major League Baseball player after his graduation from Xavier University with an Economics degree.
In our interview with Senator Bunning, we discuss the progress of Medicare Part D, Senator McCain’s healthcare proposal, and the future of American healthcare.
View interview with Senator Jim Bunning:
http://www.biggovhealth.org/testimonials/policymakers/jim-bunning/
Francois Sarkozy, MD, is currently a Managing Partner of AEC Partners, a Paris-based healthcare consultancy, and is the brother of France’s President Nicolas Sarkozy.
Dr. Sarkozy has served as a Managing Partner at AEC Partners since 2001, where his assignments have included international medical and marketing strategy, project and resource management, business development and negotiation analysis, commercialisation of new products and change management in mergers and reorganizations. Previously, during the period 1990-2000, he was Medical Director, France, for Aventis Pharma; Medical & Pharmaceutical Director, France, for Hoechst Marion Roussel, where he was also Vice President and Head of Global Portfolio & Project Management, the latter position including three years in the U.S.; earlier, he held various positions with Roussel-Uclaf, including International Development Director, International Clinical Development Head, and International Product Manager for Antibiotics. From 1983 to 1990, he was an Assistant in the Respiratory Physiology Department of the Paris Public Hospital Authority, where he also did his internship (Interne des Hopitaux de Paris) in pediatrics. He holds an MBA from INSEAD.
View interview with Dr. Francois Sarkozy:
http://www.biggovhealth.org/testimonials/policymakers/francois-sarkozy/
PHYSICIAN DISEMPOWERMENT CONFERENCE PRESENTATIONS
Francois Sarkozy, MD, AEC Partners
http://cmpi.org/uploads/File/Sarkozy-Presentation.pdf
Gary E. Applebaum, MD, CMPI Senior Fellow
http://cmpi.org/uploads/File/Dr.%20Gary%20Appleb%E2%80%A6resentation.pdf
Marc Siegel, MD, CMPI Senior Fellow
http://cmpi.org/uploads/File/Dr.%20Marc%20Siegel%E2%80%A6resentation.pdf
HIGHLIGHTS OF THE WEEK
CMPI NEWS
www.cmpi.org
Wrongheaded Medicare Reforms
By Peter J. Pitts
Front Page Magazine
October 23, 2008
Read More
Generics Are Easy; Innovation Is Hard
By Peter J. Pitts
The Journal of Life Sciences
October 17, 2008
http://www.tjols.com/article-809.html
DRUGWONKS BLOG
www.drugwonks.com
Joe The Plumber, Dan The Doctor and the McCain Health Care Plan
By Robert Goldberg
October 22, 2008
When it comes to making the tax system more progressive, truth be told, no one does more in one fell swoop in that regard than John McCain.
At least that was the point I made at a debate I participated in at Columbia University Medical Center on which health care proposal was better for America: McCain's or Obama's?
According to a report by the Lewin Group, the Obama plan -- which seeks to preserve employer based insurance -- does so by shoving about 52 million Americans into publicly funded health plans. It pays for that transition by cutting the reimbursement of doctors by at least 25 percent compared to what they get from private insurers, raising about $300 billion in taxes and cutting insurance premiums through price controls. I ignore the estimated savings from health IT and disease management because it's all based on articles published by people like me.
http://www.drugwonks.com/blog_post/show/6406
Silence Is Leaden
By Peter Pitts
October 21, 2008
The always savvy Jim Edwards has a thoughtful and important article in this week’s edition of BrandWeek. Its title, “Why Pharma Fears Social Networking,” says it all.
Almost.
Edwards writes that, “Although a majority of marketers have embraced online social media and user-generated content efforts, one industry is conspicuously not taking advantage of the gold rush: pharmaceuticals.”
His use of the term “gold rush” defines the scope of the article. He’s talking about Pharma and social networking in terms of marketing and sales. Well, it is BrandWeek after all. But there's so much more to Pharma and social networking than just marketing. But I'll get to that in a minute.
http://www.drugwonks.com/blog_post/show/6403
INTERNATIONAL ARTICLES OF NOTE
NHS Trust Spends $12,000 Treating Staff Privately
London Telegraph
October 14, 2008
Read More
Anonymous Samaritan Shames NHS Into Helping Cancer Victim With $10,000 Donation
Daily Mail
October 23, 2008
Read More
ARTICLES OF NOTE
How Obama Would Stifle Drug Innovation
Wall Street Journal
By Scott Gottlieb
October 18, 2008
http://online.wsj.com/article/SB122428260748146061.html
The Fear We Need
The American Spectator
By David Catron
October 21, 2008
http://spectator.org/archives/2008/10/21/the-fear-we-need
University of Minnesota Proposes Far-Reaching Conflict of Interest Policy
StateHouseCall
By Peter Nelson
October 23, 2008
http://healthcareblog.spn.org/university-of-minnesota-proposes-far-reaching-conflict-of-interest-policy |
